Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1989 1
1993 1
1997 1
2000 1
2001 1
2007 1
2010 2
2011 37
2012 1
2014 1
2015 2
2016 1
2017 1
2018 2
2019 3
2020 1
2021 2
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

58 results
Results by year
Filters applied: . Clear all
Page 1
Showing results for masaoka sakamoto
Your search for Masaoki Sakamoto retrieved no results
Chapter 1-1. Anaerobic infections (General): epidemiology of anaerobic infections.
Japanese Society of Chemotherapy Committee on guidelines for treatment of anaerobic infections; Japanese Association for Anaerobic Infections Research. Japanese Society of Chemotherapy Committee on guidelines for treatment of anaerobic infections, et al. J Infect Chemother. 2011 Jul;17 Suppl 1:4-12. doi: 10.1007/s10156-010-0169-y. J Infect Chemother. 2011. PMID: 21728084 Free article. Review. No abstract available.
Primary mucinous adenocarcinoma of the thymus; a rare type of thymic carcinoma. Case Report.
Tomoshige K, Tomoshi T, Keitaro M, Miyazaki T, Doi R, Machino R, Mizoguchi S, Matumoto T, Maeda Y, Nagayasu T. Tomoshige K, et al. SN Compr Clin Med. 2021 May;3(5):1233-1237. doi: 10.1007/s42399-021-00839-x. Epub 2021 Mar 6. SN Compr Clin Med. 2021. PMID: 34151190 Free PMC article.
We performed extended thymo-thymectomy with partial resection of the right upper lobe and pathologically diagnosed the patient with Masaoka stage II mucinous adenocarcinoma of the thymus. Immunohistochemistry showed the absence of PD-L1, suggesting that immune check point …
We performed extended thymo-thymectomy with partial resection of the right upper lobe and pathologically diagnosed the patient with Masao
Mutation Profile of Thymic Carcinoma and Thymic Neuroendocrine Tumor by Targeted Next-generation Sequencing.
Sakane T, Sakamoto Y, Masaki A, Murase T, Okuda K, Nakanishi R, Inagaki H. Sakane T, et al. Clin Lung Cancer. 2021 Mar;22(2):92-99.e4. doi: 10.1016/j.cllc.2020.11.010. Epub 2020 Dec 2. Clin Lung Cancer. 2021. PMID: 33414055
Prognostic analyses, conducted in thymic squamous cell carcinomas, revealed that tumor cases harboring gene mutations in RTKs, including KIT (7.4%), PDGFRA (5.6%) and EGFR (3.7%), were significantly associated with a worse overall survival time (P = .0481). Among clinicopathologi …
Prognostic analyses, conducted in thymic squamous cell carcinomas, revealed that tumor cases harboring gene mutations in RTKs, including KIT …
Survival after extended thymectomy for thymoma.
Sakamoto M, Murakawa T, Konoeda C, Inoue Y, Kitano K, Sano A, Fukayama M, Nakajima J. Sakamoto M, et al. Eur J Cardiothorac Surg. 2012 Mar;41(3):623-7. doi: 10.1093/ejcts/ezr026. Epub 2011 Oct 18. Eur J Cardiothorac Surg. 2012. PMID: 22011779
In multivariate analysis, age, Type B3 and MG were determined as prognostic factors for survival. On the other hand, Masaoka's stage did not influence survival. CONCLUSIONS: Type B3 classified by the WHO histological classification system is a poor prognostic factor …
In multivariate analysis, age, Type B3 and MG were determined as prognostic factors for survival. On the other hand, Masaoka's
Comparing intracerebral hemorrhages associated with direct oral anticoagulants or warfarin.
Kurogi R, Nishimura K, Nakai M, Kada A, Kamitani S, Nakagawara J, Toyoda K, Ogasawara K, Ono J, Shiokawa Y, Aruga T, Miyachi S, Nagata I, Matsuda S, Yoshimura S, Okuchi K, Suzuki A, Nakamura F, Onozuka D, Ido K, Kurogi A, Mukae N, Nishimura A, Arimura K, Kitazono T, Hagihara A, Iihara K; J-ASPECT Study Collaborators. Kurogi R, et al. Neurology. 2018 Mar 27;90(13):e1143-e1149. doi: 10.1212/WNL.0000000000005207. Epub 2018 Feb 28. Neurology. 2018. PMID: 29490916 Free PMC article.
Chapter 2-12-4. Anaerobic infections (individual fields): tetanus.
Japanese Society of Chemotherapy Committee on guidelines for treatment of anaerobic infections; Japanese Association for Anaerobic Infection Research. Japanese Society of Chemotherapy Committee on guidelines for treatment of anaerobic infections, et al. J Infect Chemother. 2011 Jul;17 Suppl 1:125-32. doi: 10.1007/s10156-010-0157-2. J Infect Chemother. 2011. PMID: 21728110 Free article. No abstract available.
Chapter 2-12-3. Anaerobic infections (individual fields): botulism.
Japanese Society of Chemotherapy Committee on guidelines for treatment of anaerobic infections; Japanese Association for Anaerobic Infection Research. Japanese Society of Chemotherapy Committee on guidelines for treatment of anaerobic infections, et al. J Infect Chemother. 2011 Jul;17 Suppl 1:123-4. doi: 10.1007/s10156-010-0156-3. J Infect Chemother. 2011. PMID: 21728109 Free article. No abstract available.
Chapter 2-12-1. Anaerobic infections (individual fields): actinomycosis.
Japanese Society of Chemotherapy Committee on guidelines for treatment of anaerobic infections; Japanese Association for Anaerobic Infection Research. Japanese Society of Chemotherapy Committee on guidelines for treatment of anaerobic infections, et al. J Infect Chemother. 2011 Jul;17 Suppl 1:119-20. doi: 10.1007/s10156-010-0154-5. J Infect Chemother. 2011. PMID: 21728107 Free article. No abstract available.
Chapter 2-12-5. Anaerobic infections (individual fields): necrotizing fasciitis.
Japanese Society of Chemotherapy Committee on guidelines for treatment of anaerobic infections; Japanese Association for Anaerobic Infection Research. Japanese Society of Chemotherapy Committee on guidelines for treatment of anaerobic infections, et al. J Infect Chemother. 2011 Jul;17 Suppl 1:133-4. doi: 10.1007/s10156-010-0158-1. J Infect Chemother. 2011. PMID: 21728111 Free article. No abstract available.
Chapter 2-11. Anaerobic infections (individual fields): otorhinolaryngological infections.
Japanese Society of Chemotherapy Committee on guidelines for treatment of anaerobic infections; Japanese Association for Anaerobic Infection Research. Japanese Society of Chemotherapy Committee on guidelines for treatment of anaerobic infections, et al. J Infect Chemother. 2011 Jul;17 Suppl 1:116-8. doi: 10.1007/s10156-010-0153-6. J Infect Chemother. 2011. PMID: 21728106 Free article. No abstract available.
58 results